Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
08/05/2010 | WO2010085842A1 Lung epithelial progenitor cells, uses thereof and processes for production |
08/05/2010 | WO2010065551A3 Differentiation of stem cells with nanoparticles |
08/05/2010 | WO2010062905A9 Lateral ventricle cell compositions and use for treating neural degenerative diseases |
08/05/2010 | WO2010047793A3 Cell transplantation |
08/05/2010 | WO2009148575A8 IL-1α ABS AND METHODS OF USE |
08/05/2010 | WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
08/05/2010 | US20100199391 Anti-malaria vaccine compositions and uses thereof |
08/05/2010 | US20100199384 Method for producing yellow flower by controlling flavonoid synthetic pathway |
08/05/2010 | US20100199383 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
08/05/2010 | US20100199380 Plants having enhanced yield-related traits and a method for making the same |
08/05/2010 | US20100199378 Shade tolerance in plants |
08/05/2010 | US20100199377 Ubiquitin regulatory nucleic acids, vectors, and methods of using same |
08/05/2010 | US20100199376 Protein Involved in Restoration of Cytoplasmic Male Sterility to Fertility and Gene Encoding the Protein and Gene |
08/05/2010 | US20100199368 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis |
08/05/2010 | US20100199366 Gene therapy using transposon-based vectors |
08/05/2010 | US20100199365 Desaturases and methods for producing polyunsaturated fatty acids in transgenic organisms |
08/05/2010 | US20100199364 Tnf superfamily collectin fusion proteins |
08/05/2010 | US20100199363 Enzymes for degrading herbicides |
08/05/2010 | US20100199360 Enhancer-containing gene trap vectors for random and targeted gene trapping |
08/05/2010 | US20100197895 Antibodies to human tumor necrosis factor receptor |
08/05/2010 | US20100197784 Novel curcumin analogues and uses thereof |
08/05/2010 | US20100197775 Methods and compositions for treating & diagnosing mood disorders, schizophrenia, and neuro-psychiatric disorders |
08/05/2010 | US20100197773 Compositions and methods for inhibiting expression of ptp1b genes |
08/05/2010 | US20100197772 Tissue-Specific MicroRNAs and Compositions and Uses Thereof |
08/05/2010 | US20100197769 Plasmid containing a sequence encoding a disintegrin domain of metargidin (rdd) |
08/05/2010 | US20100197768 Methods and compositions related to the structure and function of apobec3g |
08/05/2010 | US20100197765 Method for promoting the expression of p53, and p53 expression promoter for use in the method |
08/05/2010 | US20100197711 Benzothiazole compounds |
08/05/2010 | US20100197682 Organic Compounds |
08/05/2010 | US20100197659 Biphenylcarboxamide derivatives as hedgehod pathway modulators |
08/05/2010 | US20100197625 Synthetic lipophilic inositol glycans for treatment of cancer and glucose-metabolism disorders |
08/05/2010 | US20100197589 Modified growth hormone polypeptides |
08/05/2010 | US20100197583 Glycosaminoglycan-antagonising MCP-1 Mutants and Methods of Using Same |
08/05/2010 | US20100197582 Growth hormone fusion proteins |
08/05/2010 | US20100197578 Demannosylated recombinant factor viii [[vii]] for the treatment of patients with haemophilia a |
08/05/2010 | US20100197574 Aquaretic and natriuretic polypeptides lacking vasodilatory activity |
08/05/2010 | US20100197563 Compositions and methods for altering elastogenesis |
08/05/2010 | US20100197503 Mutant Hydroxyphenylpyruvate Dioxygenase Polypeptides and Methods of Use |
08/05/2010 | US20100197498 Oryza sativa ltp promoters useful for modulating gene expression in plants |
08/05/2010 | US20100197022 Automated liquid manufacturing system |
08/05/2010 | US20100197021 Keratin biomaterials for cell culture and methods of use |
08/05/2010 | US20100197020 Tissue engineering tendon and construction methods in vitro thereof |
08/05/2010 | US20100197019 Method for Cultivation of Hair Follicular Dermal Sheath Cells |
08/05/2010 | US20100197018 Use of substrates as pharmacological chaperones |
08/05/2010 | US20100197017 Method for sterilization of biological preparations |
08/05/2010 | US20100197016 Structure enclosing hematopoietic progenitor cells from ES cells and method for preparing blood cells using the same |
08/05/2010 | US20100197015 Human liver progenitors |
08/05/2010 | US20100197014 Methods for increasing definitive endoderm production |
08/05/2010 | US20100197013 Method for culturing stem cells |
08/05/2010 | US20100197012 Application of RNA Interference Targeting dhfr Gene, to Cell for Producing Secretory Protein |
08/05/2010 | US20100197011 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained |
08/05/2010 | US20100197010 Immortalized avian cell lines comprising e1a nucleic acid sequences |
08/05/2010 | US20100197009 Antibody or Fragment Thereof Recognizing AvitagTM and Uses Thereof |
08/05/2010 | US20100197008 Processing particle-containing samples |
08/05/2010 | US20100197007 Method for Culturing Mammalian Stem Cells |
08/05/2010 | US20100197006 Molecular circuits |
08/05/2010 | US20100197005 Human monoclonal antibodies to activin receptor-like kinase-1 |
08/05/2010 | US20100196978 Recombinant Host Cells and Media for Ethanol Production |
08/05/2010 | US20100196974 Chemically Inducible Expression of Biosynthetic Pathways |
08/05/2010 | US20100196970 Butynol I esterase |
08/05/2010 | US20100196966 Plants which synthesize increased amounths of glucosaminglycans |
08/05/2010 | US20100196963 Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions |
08/05/2010 | US20100196962 Il-6 receptor il-6 direct fusion protein |
08/05/2010 | US20100196960 Transporter genes oatp-b, c, d, and e |
08/05/2010 | US20100196957 Cloning and characterization of 5' flanking regions of a human aggrecanase-1 gene |
08/05/2010 | US20100196954 Modified Endoglucanase II and Methods of Use |
08/05/2010 | US20100196948 Method of screening baff suppressor or inhibitor |
08/05/2010 | US20100196929 Stabilisation of the phenotypic properties of isolated primary cells |
08/05/2010 | US20100196923 Pluripotent adult stem cells |
08/05/2010 | US20100196922 Fluorescent metal ion indicators with large stokes shifts |
08/05/2010 | US20100196919 Peptides, antibodies and fragments thereof for the treatment and diagnostic of celiac disease |
08/05/2010 | US20100196916 Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells |
08/05/2010 | US20100196910 Methods of generating human cardiac cells and tissues and uses thereof |
08/05/2010 | US20100196871 Apparatus and methods for culturing and/or transporting cellular structures |
08/05/2010 | US20100196580 Fad-2 mutants and high oleic acid plants |
08/05/2010 | US20100196499 Xenograft Bone Matrix for Orthopedic Applications |
08/05/2010 | US20100196480 Graft materials containing bioactive extracellular matrices and cells |
08/05/2010 | US20100196444 Devices with cells cultured on flexible supports |
08/05/2010 | US20100196441 Uses of immunologically modified scaffold for tissue prevascularization cell transplantation |
08/05/2010 | US20100196421 clostridial neurotoxin propeptide which has a light chain region, a heavy chain region, where the light and heavy chain regions are linked by a disulfide bond, and an intermediate region connecting the light and heavy chain regions; intermediate region has a highly specific protease cleavage site |
08/05/2010 | US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS |
08/05/2010 | US20100196410 Streptococcus pneumoniae Antigens and Vaccines |
08/05/2010 | US20100196409 Basb006 polypeptides from neisseria meningitidis and immunogenic compositions thereof |
08/05/2010 | US20100196404 Methods of use of the taci/taci-l interaction |
08/05/2010 | US20100196403 Antibody conjugates for circumventing multi-drug resistance |
08/05/2010 | US20100196397 Five-helix protein |
08/05/2010 | US20100196395 Anti-igf antibodies |
08/05/2010 | US20100196394 Anti-cancer vaccine composition |
08/05/2010 | US20100196392 Anti-system asc amino acid transporter 2 (asct2) antibody |
08/05/2010 | US20100196390 Agonist anti-trkb monoclonal antibodies |
08/05/2010 | US20100196386 Ligands of hvem for treating hematologic malignancies and autoimmune diseases |
08/05/2010 | US20100196384 Anti-histone h1 monoclonal antibody and hybridoma for the production thereof |
08/05/2010 | US20100196383 Connective Tissue Growth Factor (CTGF-3) |
08/05/2010 | US20100196381 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use |
08/05/2010 | US20100196370 Fusion protein of immunoglobulin fc and human apolipoprotein(a) kringle fragment |
08/05/2010 | US20100196355 Immunophilin Ligands and Methods for Modulating Immunophilin and Calcium Channel Activity |
08/05/2010 | US20100196349 Reeler domain containing protein |
08/05/2010 | US20100196345 Production of high mannose proteins in plant culture |
08/05/2010 | US20100196338 Compositions and methods for treating cardiovascular disease |
08/05/2010 | US20100196337 Methods and compositions for stem cell self-renewal |